Recall StatusOpen, Classified
Date Initiated2022-06-15
Product Quantity122,366 units
Reason for Recall
Various brands of SARS CoV 2 Antigen Rapid Test kits were offered for sale and distribution to consumers in the United States without marketing approval, clearance, or authorization from FDA.
Firm Action
The firm initiated their recall by email on 06/15/2022. The letter explained the issue and requested the consignee take the following actions:
"" Immediately destroy all unused product to North American Diagnostics Inc.
" Immediately identify all affected product in your inventory and segregate to avoid
inadvertent use or further distribution.
" Complete the attached response form and return it to Elizabeth Lashinsky
[email protected].
" If you have further distributed any of these products, please notify your customers
immediately with a copy of this notice, and please request that your customers destroy
any product they may have in inventory and confirm in writing that they have done so.
" If you have relabeled the product prior to distributing it, please indicate the number below and the name on the label.
If you have questions or concerns regarding this recall, or problems with the product, please contact Elizabeth A. Lashinsky, Manager,
[email protected], 407-312-7104.
Root Cause
No Marketing Application
Distribution Pattern
Worldwide distribution - US Nationwide distribution in the states of FL, LA, NV, CA, CO, AZ, CT, OH. IL, NY, DC, MD, PA, and the countries of Zambia, Austria, Canada, UAE, Bangladesh.
Official Source
View FDA Recall →Source: FDA Enforcement Report / Recall database. Always confirm against the official FDA record.